img

Global Measles and Rubella Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Measles and Rubella Vaccine Market Research Report 2024

Measles and Rubella Vaccine is a live virus vaccine used to vaccinate against measles and rubella.
According to Mr Accuracy reports new survey, global Measles and Rubella Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Measles and Rubella Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Measles and Rubella Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Serum Institute of India Pvt. Ltd.
Incepta Vaccine Ltd.
GSK
Sanofi
Segment by Type
Inactivated Vaccines
Live Attenuated Vaccines

Segment by Application


Hospital
Clinic

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Measles and Rubella Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Measles and Rubella Vaccine Market Overview
1.1 Product Overview and Scope of Measles and Rubella Vaccine
1.2 Measles and Rubella Vaccine Segment by Type
1.2.1 Global Measles and Rubella Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.3 Measles and Rubella Vaccine Segment by Application
1.3.1 Global Measles and Rubella Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Measles and Rubella Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles and Rubella Vaccine Revenue 2018-2029
1.4.2 Global Measles and Rubella Vaccine Sales 2018-2029
1.4.3 Global Measles and Rubella Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Measles and Rubella Vaccine Market Competition by Manufacturers
2.1 Global Measles and Rubella Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Measles and Rubella Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Measles and Rubella Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Measles and Rubella Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Measles and Rubella Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles and Rubella Vaccine, Product Type & Application
2.7 Measles and Rubella Vaccine Market Competitive Situation and Trends
2.7.1 Measles and Rubella Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles and Rubella Vaccine Players Market Share by Revenue
2.7.3 Global Measles and Rubella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles and Rubella Vaccine Retrospective Market Scenario by Region
3.1 Global Measles and Rubella Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Measles and Rubella Vaccine Global Measles and Rubella Vaccine Sales by Region: 2018-2029
3.2.1 Global Measles and Rubella Vaccine Sales by Region: 2018-2024
3.2.2 Global Measles and Rubella Vaccine Sales by Region: 2024-2029
3.3 Global Measles and Rubella Vaccine Global Measles and Rubella Vaccine Revenue by Region: 2018-2029
3.3.1 Global Measles and Rubella Vaccine Revenue by Region: 2018-2024
3.3.2 Global Measles and Rubella Vaccine Revenue by Region: 2024-2029
3.4 North America Measles and Rubella Vaccine Market Facts & Figures by Country
3.4.1 North America Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Measles and Rubella Vaccine Sales by Country (2018-2029)
3.4.3 North America Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles and Rubella Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Measles and Rubella Vaccine Sales by Country (2018-2029)
3.5.3 Europe Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles and Rubella Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Measles and Rubella Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Measles and Rubella Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Measles and Rubella Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles and Rubella Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Measles and Rubella Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles and Rubella Vaccine Sales by Type (2018-2029)
4.1.1 Global Measles and Rubella Vaccine Sales by Type (2018-2024)
4.1.2 Global Measles and Rubella Vaccine Sales by Type (2024-2029)
4.1.3 Global Measles and Rubella Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Measles and Rubella Vaccine Revenue by Type (2018-2029)
4.2.1 Global Measles and Rubella Vaccine Revenue by Type (2018-2024)
4.2.2 Global Measles and Rubella Vaccine Revenue by Type (2024-2029)
4.2.3 Global Measles and Rubella Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Measles and Rubella Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Measles and Rubella Vaccine Sales by Application (2018-2029)
5.1.1 Global Measles and Rubella Vaccine Sales by Application (2018-2024)
5.1.2 Global Measles and Rubella Vaccine Sales by Application (2024-2029)
5.1.3 Global Measles and Rubella Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Measles and Rubella Vaccine Revenue by Application (2018-2029)
5.2.1 Global Measles and Rubella Vaccine Revenue by Application (2018-2024)
5.2.2 Global Measles and Rubella Vaccine Revenue by Application (2024-2029)
5.2.3 Global Measles and Rubella Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Measles and Rubella Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Measles and Rubella Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Serum Institute of India Pvt. Ltd.
6.2.1 Serum Institute of India Pvt. Ltd. Corporation Information
6.2.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.2.3 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product Portfolio
6.2.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.3 Incepta Vaccine Ltd.
6.3.1 Incepta Vaccine Ltd. Corporation Information
6.3.2 Incepta Vaccine Ltd. Description and Business Overview
6.3.3 Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Incepta Vaccine Ltd. Measles and Rubella Vaccine Product Portfolio
6.3.5 Incepta Vaccine Ltd. Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GSK Measles and Rubella Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Sanofi Measles and Rubella Vaccine Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles and Rubella Vaccine Industry Chain Analysis
7.2 Measles and Rubella Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles and Rubella Vaccine Production Mode & Process
7.4 Measles and Rubella Vaccine Sales and Marketing
7.4.1 Measles and Rubella Vaccine Sales Channels
7.4.2 Measles and Rubella Vaccine Distributors
7.5 Measles and Rubella Vaccine Customers
8 Measles and Rubella Vaccine Market Dynamics
8.1 Measles and Rubella Vaccine Industry Trends
8.2 Measles and Rubella Vaccine Market Drivers
8.3 Measles and Rubella Vaccine Market Challenges
8.4 Measles and Rubella Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Measles and Rubella Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Measles and Rubella Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Measles and Rubella Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Measles and Rubella Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Measles and Rubella Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Measles and Rubella Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Measles and Rubella Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Measles and Rubella Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Measles and Rubella Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Measles and Rubella Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Measles and Rubella Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Measles and Rubella Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Measles and Rubella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles and Rubella Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Measles and Rubella Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Measles and Rubella Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Measles and Rubella Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Measles and Rubella Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Measles and Rubella Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Measles and Rubella Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Measles and Rubella Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Measles and Rubella Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Measles and Rubella Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Measles and Rubella Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Measles and Rubella Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Measles and Rubella Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Measles and Rubella Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Measles and Rubella Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Measles and Rubella Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Measles and Rubella Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Measles and Rubella Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Measles and Rubella Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Measles and Rubella Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Measles and Rubella Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Measles and Rubella Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Measles and Rubella Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Measles and Rubella Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Measles and Rubella Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Measles and Rubella Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Measles and Rubella Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Measles and Rubella Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Measles and Rubella Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Measles and Rubella Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Measles and Rubella Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Measles and Rubella Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Measles and Rubella Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Measles and Rubella Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Measles and Rubella Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Measles and Rubella Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Measles and Rubella Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Measles and Rubella Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Measles and Rubella Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Measles and Rubella Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Measles and Rubella Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Measles and Rubella Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Measles and Rubella Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Measles and Rubella Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Measles and Rubella Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Measles and Rubella Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Measles and Rubella Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Measles and Rubella Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Measles and Rubella Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Measles and Rubella Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Measles and Rubella Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Measles and Rubella Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Measles and Rubella Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Measles and Rubella Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Measles and Rubella Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Measles and Rubella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Merck Measles and Rubella Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Serum Institute of India Pvt. Ltd. Corporation Information
Table 76. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 77. Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product
Table 79. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 80. Incepta Vaccine Ltd. Corporation Information
Table 81. Incepta Vaccine Ltd. Description and Business Overview
Table 82. Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Incepta Vaccine Ltd. Measles and Rubella Vaccine Product
Table 84. Incepta Vaccine Ltd. Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Measles and Rubella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. GSK Measles and Rubella Vaccine Product
Table 89. GSK Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Measles and Rubella Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Sanofi Measles and Rubella Vaccine Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Measles and Rubella Vaccine Distributors List
Table 98. Measles and Rubella Vaccine Customers List
Table 99. Measles and Rubella Vaccine Market Trends
Table 100. Measles and Rubella Vaccine Market Drivers
Table 101. Measles and Rubella Vaccine Market Challenges
Table 102. Measles and Rubella Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measles and Rubella Vaccine
Figure 2. Global Measles and Rubella Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Measles and Rubella Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Live Attenuated Vaccines Product Picture
Figure 6. Global Measles and Rubella Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Measles and Rubella Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Measles and Rubella Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Measles and Rubella Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Measles and Rubella Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Measles and Rubella Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Measles and Rubella Vaccine Report Years Considered
Figure 15. Measles and Rubella Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Measles and Rubella Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Measles and Rubella Vaccine Players: Market Share by Revenue in 2022
Figure 18. Measles and Rubella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Measles and Rubella Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Measles and Rubella Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Measles and Rubella Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Measles and Rubella Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Measles and Rubella Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Measles and Rubella Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Measles and Rubella Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Measles and Rubella Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Measles and Rubella Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Measles and Rubella Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Measles and Rubella Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Measles and Rubella Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Measles and Rubella Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Measles and Rubella Vaccine by Type (2018-2029)
Figure 54. Global Measles and Rubella Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Measles and Rubella Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Measles and Rubella Vaccine by Application (2018-2029)
Figure 57. Global Measles and Rubella Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Measles and Rubella Vaccine Value Chain
Figure 59. Measles and Rubella Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed